Researchers Identify ‘Multiple Potential Therapeutic Targets’ for Preventing Hearing Loss Caused by Aminoglycosides
INDIANAPOLIS, INDIANA — Researchers at Indiana University School of Medicine are developing new ways to study why an antibiotic causes hair cell death and permanent hearing loss in people. In a study recently published in Developmental Cell, the researchers explained how they identified the autophagy pathway in hair cells that’s linked to permanent hearing loss brought…
Read More
Alzheimer’s Association Announces Appointment of Starkey’s Michael Scholl to Board
The Alzheimer’s Association Minnesota-North Dakota announced the appointment of Michael Scholl to its board of directors today. He serves as Chief Compliance Officer and Executive Vice President of Corporate Relations at Starkey. Scholl joins 18 other volunteer board members committed to the nonprofit’s work in providing no-cost care and support resources for families impacted by…
Read More
Voting Is Now Open for 2022 Oticon Focus on People Awards
SOMERSET, NEW JERSEY – Voting is now open for the 2022 Oticon Focus on People Awards at Oticon.com/FOP . Website visitors are invited to cast their votes for the 12 finalists who represent the “best of the best” from this year’s nominations in each of four categories – Student, Adult, Advocacy and Practitioner. The total…
Read More
New Study Challenges Current Knowledge About How Inner Ear Detects Low-Frequency Sound
Scientists have discovered the cochlea in the inner ear detects low-frequency sound in a manner very different than previously known, according to new research from scientists at Oregon Health & Science University and Linköping University in Sweden. The finding, published in the journal Science Advances, may make it possible to design better cochlear implants for people with…
Read More
Noah ES Surpasses 500 User Milestone
COPENHAGEN, DENMARK – HIMSA has announced that Noah ES, its new cloud-enabled Noah solution released last February in the USA and Europe, has now surpassed the 500 user milestone. Since its release seven months ago, Noah ES has steadily grown, and cloud performance has steadily improved. “When talking to our Noah ES users, one of…
Read More
FDA Approves PEDMARK® to Reduce Hearing Loss Risk in Pediatric Patients Undergoing Cisplatin Chemotherapy
RESEARCH TRIANGLE PARK, NORTH CAROLINA — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved PEDMARK® (sodium thiosulfate injection) to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors.…
Read More
Decibel Therapeutics Announces Submission of IND Application for Lead Gene Therapy Candidate DB-OTO
BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 1/2 clinical trial in pediatric patients of DB-OTO,…
Read More
FCOM 2022 to Take Place in Boca Raton, November 11-13
The Florida Combined Otolaryngology Meeting (FCOM) includes the Florida Society of Otolaryngology Head and Neck Surgery (FSO-HNS), the Florida Society of Facial Plastic and Reconstructive Surgery (FSFPRS), the Network of Florida Otolaryngologists (NFO) and the Network of Medical Audiology Professionals (MedAudPro) has a speaker lineup of more than 120 presenters for its 26th annual meeting.…
Read More
Tuned Raises $2.5M Seed Round with Aim to ‘Radically Upend Status Quo’ in Hearing Care
NEW YORK CITY, NEW YORK — Tuned, a hearing health company focused on providing hearing care for all, today announced that it raised $2.5 million in seed funding, led by Idealab NY and Elements Health Ventures. Following successful pilots with companies such as RetailBound and Mishe, the injection of new capital will be used to scale employer adoption and…
Read More
Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF
BOSTON, MASSACHUSSETTS — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 1/2, first in human,…
Read More